Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

2.02
Delayed Data
As of 2:35pm ET
 +0.01 / +0.50%
Today’s Change
1.72
Today|||52-Week Range
3.22
-3.35%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close2.01
Today’s open1.99
Day’s range1.99 - 2.08
Volume4,457
Average volume (3 months)32,770
Market cap$34.5M
Dividend yield--
Data as of 2:35pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)+42.50%
Earnings growth (this year)-4.75%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
OPXAOpexa Therapeutics I...-0.13-2.67%
PPHMPPeregrine Pharmaceut...-0.27-1.17%
CTRVContraVir Pharmaceut...-0.02-1.74%
PRPHProPhase Labs Inc+0.09+4.81%
Data as of 2:39pm ET, 08/24/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers

Search for Jobs